Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Maryam Asgari to Keratinocytes

This is a "connection" page, showing publications Maryam Asgari has written about Keratinocytes.

 
Connection Strength
 
 
 
2.060
 
  1. Kim Y, Wojciechowski D, Pattanayak V, Lee H, Asgari MM. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients. J Invest Dermatol. 2020 05; 140(5):995-1002.
    View in: PubMed
    Score: 0.621
  2. Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis. JAMA Dermatol. 2020 10 01; 156(10):1066-1073.
    View in: PubMed
    Score: 0.166
  3. Ashrafzadeh S, Kim Y, Peters GA, Lee H, Asgari MM. Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa. Br J Dermatol. 2020 11; 183(5):962-964.
    View in: PubMed
    Score: 0.163
  4. Choquet H, Ashrafzadeh S, Kim Y, Asgari MM, Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020 05 21; 5(10).
    View in: PubMed
    Score: 0.162
  5. Kim Y, Jorgenson E, Asgari MM. Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis. Br J Dermatol. 2020 09; 183(3):415-416.
    View in: PubMed
    Score: 0.161
  6. Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res. 2019 04 15; 25(8):2379-2391.
    View in: PubMed
    Score: 0.146
  7. Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A?cohort study. J Am Acad Dermatol. 2019 Apr; 80(4):998-1005.
    View in: PubMed
    Score: 0.146
  8. Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE. Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma. Br J Dermatol. 2017 11; 177(5):1150-1151.
    View in: PubMed
    Score: 0.135
  9. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
    View in: PubMed
    Score: 0.134
  10. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-12, quiz 815-6.
    View in: PubMed
    Score: 0.096
  11. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-11; quiz 827-8.
    View in: PubMed
    Score: 0.096
  12. Tang H, Fu S, Zhai S, Song Y, Asgari MM, Han J. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2018 03; 27(3):279-288.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)